Howard Liang

2019

In 2019, Howard Liang earned a total compensation of $4.2M as Chief Financial Officer and Chief Strategy Officer at BeiGene, Ltd., a 6% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$251,213
Option Awards$2,799,967
Salary$435,000
Stock Awards$699,967
Other$8,400
Total$4,194,547

Liang received $2.8M in option awards, accounting for 67% of the total pay in 2019.

Liang also received $251.2K in non-equity incentive plan, $435K in salary, $700K in stock awards and $8.4K in other compensation.

Rankings

In 2019, Howard Liang's compensation ranked 2,810th out of 13,971 executives tracked by ExecPay. In other words, Liang earned more than 79.9% of executives.

ClassificationRankingPercentile
All
2,810
out of 13,971
80th
Division
Manufacturing
1,016
out of 5,701
82nd
Major group
Chemicals And Allied Products
336
out of 2,200
85th
Industry group
Drugs
273
out of 1,886
86th
Industry
Pharmaceutical Preparations
202
out of 1,398
86th
Source: SEC filing on April 28, 2020.

Liang's colleagues

We found four more compensation records of executives who worked with Howard Liang at BeiGene, Ltd. in 2019.

2019

John Oyler

BeiGene, Ltd.

Chief Executive Officer

2019

Xiaobin Wu

BeiGene, Ltd.

General Manager of China and President

2019

Jane Huang

BeiGene, Ltd.

Chief Medical Officer

2019

Amy Peterson

BeiGene, Ltd.

Chief Medical Officer

News

In-depth

You may also like